Carbamazepine (Tegretol): Uses, Warnings, and Key Facts

What is carbamazepine?

Carbamazepine is a medicine used in several neurological and psychiatric conditions. The original content lists its use in epileptic seizures, neuralgia, alcohol withdrawal syndrome, and prophylaxis of manic-depressive illness.

Because brand names and formulations can vary, it is important to confirm the exact product, strength, and release type on the package or leaflet.

Brand names mentioned

The source content lists the following U.S. brand names: Tegretol, Epitol, Tegretol XR, and Carbatrol.

How carbamazepine works

The original content describes carbamazepine as reducing glutamate release, stabilizing neuronal membranes, and depressing dopamine and noradrenaline exchange.

In practical terms, it acts on the nervous system, which helps explain both its therapeutic uses and some of its common side effects.

Therapeutic uses listed in the source

How it is taken

The source says carbamazepine may be taken during, after, or between meals with a little liquid.

It also notes that plasma levels may be monitored to help optimize dosing. Exact dose changes should be guided by the prescribing clinician and the official product information.

Dosage information included in the source

The original content provides example dosing ranges for adults and children for certain uses. Because dosing depends on the condition, age, formulation, and individual response, readers should verify the exact instructions on the prescription label and official leaflet.

Contraindications listed in the source

• Hypersensitivity to carbamazepine or structurally related drugs, such as tricyclic antidepressants.
• Atrioventricular block.
• History of bone marrow depression.
• Hepatic porphyrias, including intermittent acute porphyria and variegate porphyria.
• Use with MAO inhibitors, or within 2 weeks after them.

Warnings and precautions

• Extra caution is noted in older adults.
• Blood disorders such as aplastic anemia, agranulocytosis, thrombocytopenia, or leukopenia may appear.
• Treatment may need review if bone marrow depression, severe skin reactions, worsening liver dysfunction, active liver disease, or worsening seizures occur.
• It may reduce the effectiveness of oral contraceptives.
• Monitoring may be needed in pregnancy, in children and adolescents, in absorption disorders, or if seizures increase.
• The source advises gradual suspension rather than abrupt stopping.
• Cross-sensitivity with oxcarbazepine and phenytoin is mentioned.
• Caution is noted in mixed seizures that include absences and in high intraocular pressure.
• It may activate latent psychosis.
• Risk/benefit should be assessed in people with cardiac, hepatic, renal, or hematological histories.
• The source recommends monitoring hemogram, hepatic function, and urine analysis.
• Multiorgan hypersensitivity reactions and suicidal thoughts or behaviors are mentioned as safety concerns to watch for.

Liver and kidney considerations

Liver failure

The source advises caution in people with a history of liver disease and says treatment should be suspended if liver dysfunction worsens or active liver disease appears.

Kidney failure

The source also advises caution in people with a history of kidney disease.

Drug and food interactions

Carbamazepine has many interactions. The original content lists medicines and substances that may increase carbamazepine levels, decrease its levels, or change the effect of other drugs.

Because interaction lists can be extensive and product-specific, it is important to check the official leaflet and ask a pharmacist or prescriber before combining it with any other medicine, including over-the-counter products and herbal supplements.

Examples mentioned in the source

• Levels may increase with some CYP3A4 inhibitors, grapefruit juice, and several other medicines listed in the source.
• Levels may decrease with enzyme inducers such as phenobarbital, phenytoin, primidone, rifampicin, and St. John’s wort (H. perforatum).
• It may reduce the effect of oral contraceptives, some antiepileptics, some antipsychotics, warfarin-like anticoagulants, cyclosporine, digoxin, methadone, levothyroxine, and others listed in the source.
• Alcohol tolerance may be reduced.

Pregnancy and breastfeeding

The source states that developmental disorders have been reported in humans, including spina bifida, craniofacial defects, and cardiovascular and other abnormalities.

It also mentions vitamin K1 administration to the mother in the last weeks and to the child to help avoid bleeding. This is a medical decision that should be made by a clinician.

Breastfeeding

Carbamazepine passes into breast milk. The source says the benefits of breastfeeding should be weighed against the possibility of adverse effects in the child, such as excessive drowsiness or allergic skin reactions.

Effects on driving and machinery

Carbamazepine can cause drowsiness, dizziness, visual changes, and reduced reaction ability. The source advises caution when driving or operating dangerous machinery, especially until individual sensitivity is known.

Possible adverse reactions

• Dizziness
• Ataxia
• Drowsiness
• Fatigue
• Headache
• Diplopia
• Accommodation disorders
• Allergic skin reactions
• Urticaria
• Leucopenia
• Eosinophilia
• Thrombocytopenia
• Increased gamma-GT and alkaline phosphatase
• Nausea
• Vomiting
• Dry mouth
• Edema
• Weight gain
• Hyponatremia
• Reduced plasma osmolality

What to verify with the official leaflet

If you are looking at a carbamazepine product, it is sensible to confirm the following in the official medication guide or with a pharmacist:

• The exact brand and formulation, especially if it is immediate-release or extended-release.
• The approved use for that specific product.
• The correct way to take it with food or liquid.
• Interaction warnings with your current medicines, supplements, and alcohol.
• Any pregnancy, breastfeeding, liver, kidney, or blood-monitoring advice.

Frequently asked questions

Sources and references

The original content states that it was written using clinical and molecular information from medicines authorized and marketed in the United States under the Unique Ingredient Identifier (UNII) by the FDA Substance Registration System and the United States Pharmacopeia.

For official product-specific details, consult the FDA medication guide and the resources below.

• FDA Medication Guide database
• UNII: 33CM23913M
• ChemIDplus
• DrugPortal
• PubChem CID: 2554
• NCI Thesaurus: C341